Adora Ndu - 12 Oct 2022 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
Director
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Issuer symbol
ACAD
Transactions as of
12 Oct 2022
Net transactions value
$0
Form type
4
Filing time
14 Oct 2022, 19:09:39 UTC
Previous filing
11 Jun 2021
Next filing
05 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Stock Option (Right to Buy) Award $0 +14,077 $0.000000 14,077 12 Oct 2022 Common Stock 14,077 $17.12 Direct F1
transaction ACAD Restricted Stock Units Award $0 +8,762 $0.000000 8,762 12 Oct 2022 Common Stock 8,762 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option shall vest in two equal annual installments commencing on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of Acadia common stock.
F3 The restricted stock units shall vest in two equal annual installments commencing on the first anniversary of the grant date.